The approach was to mix wild type α6+ epithelial progenitor cells at various percentages (1%-8%) with bronchial epithelial cells from patients with CF, and then study CFTR-mediated current in response to agents that increase cAMP levels (forskolin+IBMX). Here, CFTR is linked to cystic fibrosis.